Does heliox administered by low-flow nasal cannula improve respiratory distress in infants with respiratory syncytial virus acute bronchiolitis? A randomised controlled trial

Objectives null The aim of our study is to evaluate whether the use of heliox (79:21) delivered through a low flow nasal cannula would improve respiratory distress in infants with acute bronchiolitis caused by RSV. null null null Methods null We have conducted a prospective randomised controlled study. All patients fulfilling inclusion criteria were randomised to either heliox (79:21) or air via NC at 2 L/min for a continuous 24 h. Measurements...